AnaptysBio (ANAB) Stock Chart & Stock Price History $26.86 +0.23 (+0.86%) Closing price 04:00 PM EasternExtended Trading$28.69 +1.83 (+6.81%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 22.10%, with a year-to-date return of 102.87%. In the past month, the stock has increased 12.38%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $26.63 with a market cap of $782.39 million and volume of 341,750 shares. Five years ago, the stock traded at $21.86, representing a 22.87% increase over that period. At the time, it had a market cap of $585.64 million and a volume of 307,900 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.52%1 Month Performance+12.38%3 Month Performance+40.92%Year-To-Date Performance+102.87%1 Year Performance-22.10%5 Year Performance+22.87% ANAB Stock Chart for Wednesday, July, 16, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$26.95$26.63-1.19%$27.22$26.12341,750 shs$782.39 million07/14/2025$26.20$26.95+2.86%$27.12$26.03244,155 shs$791.79 million07/11/2025$26.09$26.20+0.42%$26.70$25.44338,707 shs$769.76 million07/10/2025$25.74$26.09+1.36%$26.16$25.24462,541 shs$766.52 million07/09/2025$24.25$25.74+6.14%$26.17$23.99895,981 shs$756.24 million07/08/2025$23.45$24.25+3.41%$24.73$23.261.03 million shs$712.47 million07/07/2025$24.05$23.45-2.47%$24.20$23.10448,281 shs$688.96 million07/04/2025$24.05$24.05$24.13$23.51212,764 shs$706.44 million07/03/2025$23.88$24.05+0.69%$24.13$23.51212,764 shs$706.44 million07/02/2025$22.65$23.88+5.43%$24.69$22.43669,369 shs$701.59 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$22.20$22.65+2.03%$23.09$21.87336,072 shs$665.46 million06/30/2025$22.47$22.20-1.20%$22.83$21.96525,155 shs$652.24 million06/27/2025$23.38$22.47-3.89%$23.53$22.19545,336 shs$660.17 million06/26/2025$23.24$23.38+0.60%$24.86$22.89298,242 shs$686.90 million06/25/2025$23.32$23.24-0.34%$23.59$22.49366,689 shs$682.79 million06/24/2025$22.82$23.32+2.19%$23.80$22.90403,991 shs$685.14 million06/23/2025$23.17$22.82-1.51%$23.94$22.35439,599 shs$670.45 million06/20/2025$23.39$23.17-0.94%$23.45$22.51454,361 shs$680.74 million06/19/2025$23.39$23.39$24.17$23.03419,414 shs$687.20 million06/18/2025$23.82$23.39-1.81%$24.17$23.03419,414 shs$687.20 million06/17/2025$23.90$23.82-0.33%$24.15$23.49525,264 shs$699.83 million06/16/2025$23.32$23.90+2.49%$24.03$22.66554,548 shs$702.18 million Related Companies Crinetics Pharmaceuticals Stock Chart Alvotech Stock Chart HUTCHMED Stock Chart AMNEAL PHARMACEUTICALS Stock Chart Catalyst Pharmaceuticals Stock Chart Bausch Health Cos Stock Chart Organon & Co. Stock Chart Xenon Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart ImmunityBio Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
